Abstract
The term “neurodevelopmental disorder” broadly encompasses conditions thought to arise early in development and includes schizophrenia, bipolar disorder and autism among others. These conditions share a number of genetic and environmental risk factors postulated to lead to common difficulties in socio-emotional processing, communication and cognitive function. The alternative position is that, while the same traits are affected across these conditions, the nature or direction in which they are modified may be distinct. MRI studies provide a rapidly expanding and rich database which we propose can be used to contribute to this debate. Anatomical likelihood estimation (ALE) is a method of meta-analysis applied to voxel-based MRI studies. We have adapted this method to explore the extent to which schizophrenia and bipolar disorder and schizophrenia and autism share a common brain structural phenotype. We will review this work here and discuss whether there is sufficient other evidence to justify a common framework for further research into the inter-relatedness of such conditions.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Carroll L S, Owen M J. Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med, 2009, 1: 102
Burbach J P, van der Zwaag B. Contact in the genetics of autism and schizophrenia. Trends Neurosci, 2009, 32: 69–72
Verdoux H. Perinatal risk factors for schizophrenia: How specific are they? Curr Psychiatry Rep, 2004, 6: 162–167
Frith C D, Frith U. Interacting minds-A biological basis. Science, 1999, 286: 1692–1695
Mazza M, Di Michele V, Pollice R, et al. Pragmatic language and theory of mind deficits in people with schizophrenia and their relatives. Psychopathology, 2008, 41: 254–263
Greene C M, Braet W, Johnson K A, et al. Imaging the genetics of executive function. Biol Psychol, 2008, 79: 30–42
Chua S E, Cheung C, Cheung V, et al. Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res, 2007, 89: 12–21
McAlonan G M, Cheung V, Cheung C, et al. Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain, 2005, 128: 268–276
McAlonan G M, Daly E, Kumari V, et al. Brain anatomy and sensorimotor gating in Asperger’s syndrome. Brain, 2002, 125: 1594–1606
Laird A R, Fox P M, Price C J, et al. ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum Brain Mapp, 2005, 25: 155–164
Turkeltaub P E, Eden G F, Jones K M, et al. Meta-analysis of the functional neuroanatomy of single-word reading: Method and validation. Neuroimage, 2002, 16: 765–780
Wright I C, Rabe-Hesketh S, Woodruff P W, et al. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry, 2000, 157: 16–25
Chan R C, Di X, McAlonan G M, et al. Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: An activation likelihood estimation meta-analysis of illness progression. Schizophr Bull, 2011, 37: 177–188
Li H, Chan R C K, McAlonan G M, et al. Facial emotion processing in schizophrenia: A meta-analysis of functional neuroimaging data. Schizophr Bull, 2010, 36: 1029–1039
Ellison-Wright I, Glahn D C, Laird A R, et al. The anatomy of first-episode and chronic schizophrenia: An anatomical likelihood estimation meta-analysis. Am J Psychiatry, 2008, 165: 1015–1023
Glahn D C, Laird A R, Ellison-Wright I, et al. Meta-analysis of gray matter anomalies in schizophrenia: Application of anatomic likelihood estimation and network analysis. Biol Psychiatry, 2008, 64: 774–781
Leung M, Cheung C, Yu K, et al. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull, 2011, 37: 199–211
Deng M Y, McAlonan G M, Cheung C, et al. A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naive, newly diagnosed schizophrenia. Psychopharmacology, 2009, 206: 437–446
Ho B C, Andreasen N C, Ziebell S, et al. Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry, 68: 128–137
Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: A meta-analysis. Schizophr Res, 2010, 117: 1–12
Yu K, Cheung C, Leung M, et al. Are bipolar disorder and schizophrenia neuroanatomically distinct? An anatomical likelihood meta-analysis. Front Hum Neurosci, 2010, 4: 189
Green M F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry, 2006, 67(Suppl 9): 3–8
Llewellyn S. Is ‘bipolar disorder’ the brain’s autopoietic response to schizophrenia? Med Hypotheses, 2009, 73: 580–584
Shifman S, Bronstein M, Sternfeld M, et al. COMT: A common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet, 2004, 128B: 61–64
Green E K, Raybould R, Macgregor S, et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry, 2005, 62: 642–648
Maynard T M, Haskell G T, Peters A Z, et al. A comprehensive analysis of 22q11 gene expression in the developing and adult brain. Proc Natl Acas Sci USA, 2003, 100: 14433–14438
Hashimoto R, Okada T, Kato T, et al. The breakpoint cluster region gene on chromosome 22q11 is associated with bipolar disorder. Biol Psychiatry, 2005, 57: 1097–1102
Lichtenstein P, Yip B H, Bjork C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet, 2009, 373: 234–239
van Os J, Kapur S. Schizophrenia. Lancet, 2009, 374: 635–645
Smalley S L, McCracken J, Tanguay P. Autism, affective disorders, and social phobia. Am J Med Genet, 1995, 60: 19–26
Bolton P F, Pickles A, Murphy M, et al. Autism, affective and other psychiatric disorders: Patterns of familial aggregation. Psychol Med, 1998, 28: 385–395
Ghaziuddin M. A family history study of Asperger syndrome. J Autism Dev Disord, 2005, 35: 177–182
Daniels J L, Forssen U, Hultman C M, et al. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics, 2008, 121: e1357–1362
Larsson H J, Eaton W W, Madsen K M, et al. Risk factors for autism: Perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol, 2005, 161: 916–925
Goodman A B. A family history study of schizophrenia spectrum disorders suggests new candidate genes in schizophrenia and autism. Psychiatr Q, 1994, 65: 287–297
Crespi B, Badcock C. Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci, 2008, 31: 241–261; discussion 261–320
Crespi B, Stead P, Elliot M. Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia. Proc Natl Acad Sci USA, 107(Suppl 1): 1736–1741
McAlonan G M, Li Q, Cheung C. The timing and specificity of prenatal immune risk factors for autism modeled in the mouse and relevance to schizophrenia. Neurosignals, 2010, 18: 129–139
Grant W B, Soles C M. Epidemiologic evidence supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism. Dermatoendocrinol, 2009, 1: 223–228
Mackay-Sim A, Feron F, Eyles D, et al. Schizophrenia, vitamin D, and brain development. Int Rev Neurobiol, 2004, 59: 351–380
Atladottir H O, Thorsen P, Ostergaard L, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord, 2010, 40: 1423–1430
Chess S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr, 1977, 7: 69–81
Juul-Dam N, Townsend J, Courchesne E. Prenatal, perinatal, and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population. Pediatrics, 2001, 107: E63
Libbey J E, Sweeten T L, McMahon W M, et al. Autistic disorder and viral infections. J Neurovirol, 2005, 11: 1–10
Adams W, Kendell R E, Hare E H, et al. Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia. An analysis of Scottish, English, and Danish data. Br J Psychiatry, 1993, 163: 522–534
Brown A S. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull, 2006, 32: 200–202
Brown A S, Begg M D, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry, 2004, 61: 774–780
Brown A S, Susser E S. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev, 2002, 8: 51–57
Cheung C, Yu K, Fung G, et al. Autistic disorders and schizophrenia: Related or remote? An anatomical likelihood estimation. PLoS ONE, 2010, 5: e12233
Geschwind D H, Levitt P. Autism spectrum disorders: Developmental disconnection syndromes. Curr Opin Neurobiol, 2007, 17: 103–111
Wolff S. ’schizoid’ personality in childhood and adult life. III: The childhood picture. Br J Psychiatry, 1991, 159: 629–635
Nieminen-von Wendt T, Metsahonkala L, Kulomaki T A, et al. Increased presynaptic dopamine function in Asperger syndrome. Neuroreport, 2004, 15: 757–760
Lindstrom L H, Gefvert O, Hagberg G, et al. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. Biol Psychiatry, 1999, 46: 681–688
Craig J S, Hatton C, Craig F B, et al. Persecutory beliefs, attributions and theory of mind: Comparison of patients with paranoid delusions, Asperger’s syndrome and healthy controls. Schizophr Res, 2004, 69: 29–33
Rausch J L, Sirota E L, Londino D L, et al. Open-label risperidone for Asperger’s disorder: Negative symptom spectrum response. J Clin Psychiatry, 2005, 66: 1592–1597
Cadenhead K S, Geyer M A, Braff D L. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry, 1993, 150: 1862–1867
Cadenhead K S, Swerdlow N R, Shafer K M, et al. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: Evidence of inhibitory deficits. Am J Psychiatry, 2000, 157: 1660–1668
Perry W, Minassian A, Lopez B, et al. Sensorimotor gating deficits in adults with autism. Biol Psychiatry, 2007, 61: 482–486
Braff D L, Geyer M A, Swerdlow N R. Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology, 2001, 156: 234–258
Geyer M. The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps? Neurotoxicol Res, 2006, 10: 211–220
Chua S E, Deng Y, Chen E Y, et al. Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment. Psychol Med, 2009, 39: 793–800
Moore G J, Bebchuk J M, Wilds I B, et al. Lithium-induced increase in human brain grey matter. Lancet, 2000, 356: 1241–1242
Bachmann R F, Schloesser R J, Gould T D, et al. Mood stabilizers target cellular plasticity and resilience cascades: Implications for the development of novel therapeutics. Mol Neurobiol, 2005, 32: 173–202
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
McAlonan, G.M., Yu, K.K., Chan, R.C.K. et al. Is there an anatomical endophenotype for neurodevelopmental disorders? A review of dual disorder anatomical likelihood estimation (ALE) meta-analyses of grey matter volumes. Chin. Sci. Bull. 56, 3376–3381 (2011). https://doi.org/10.1007/s11434-011-4743-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-011-4743-1